Shaping the future of epigenetics and stem cell research

Two Institute Directors share their view

Welcome to the Institutes of Function Epigenetics and Epigenetics & Stem Cells at the Helmholtz Zentrum München. Epigenetic mechanisms contribute to the development of common diseases, play a key role in transmitting certain environmental signals that predispose for disease states and form the foundations of cellular reprogramming and potency. While many advances have been made in the field, it is important to develop a more interconnected and global view on epigenetics and chromatin-based mechanisms and their impact on health.

The key to this endeavor is a number of strategic actions. One such action is the joint international group leader recruitment campaigns that aim to foster cutting edge research in the area of epigenetics and chromatin biology, as well as cellular plasticity and stem cells. We wish to develop a vibrant, inspiring and internationally competitive research environment, promoting creativity and the generation and sharing of new ideas. The Institutes are currently composed of researchers of 16 different nationalities expert in a range of scientific disciplines, which we believe to be highly enriching and contributes to enlarging ones horizons, at both a personal and research level.

In keeping with a larger, open outlook on epigenetics and stem cells, we aim to collaborate with other Institutes on campus, to bridge a range of topics including the cross-talk between the environment and metabolism with the (epi)genome as well as stem cell biology, thereby contributing to the broader strategic lines of the Helmholtz Zentrum München. This is embedded in the larger context of networks and partnerships in Munich, a hot spot for innovative research hosting several of Germany’s top universities and research institutions such as LMU, TUM and Max Planck Institutes.

Please navigate through the tabs on the right to get a flavor of how we wish to develop a highly dynamic working environment for the epigenetics and stem cell field at large.